FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
Download PDF Read more
Download PDF Read more
Shimadzu Environmental and Social Report 2016 Read more
CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B... Read more
Solomon honored for her leadership in developing nucleic-acid and microfluidic products SANTA CLARA, Calif., Feb. 23, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Dr. Darlene Solomon, Agilent senior vice president and chief technology officer, has been elected to the National Academy of Engineering — considered among the highest professional distinctions accorded to an... Read more
By combining optical and electrical simulation with high-pressure freezing it is now possible to capture fast cellular dynamics with millisecond precision. In a webinar on March 29 Dr. Shigeki Watanabe and Dr. Frédéric Leroux will present results of recent studies that demonstrate how this new method can help to resolve controversial questions in neurobiology. The... Read more